Skip to main content

Table 1 Main patient characteristics

From: Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients

Characteristic

N o. of patients

%

Patients evaluable

41

100

Age, years

  

Median

60

/

Range

32-75

 

ECOG PS

  

0

13

32

1

21

51

2

7

17

Tumor histology/citology

  

Serous adenocarcinoma

10

24.5

Adenocarcinoma

7

17

Papillary serous

6

15

Clear cell adenocarcinoma

2

5

Endometrioid

3

7

Mucinous adenocarcinoma

3

7

Poorly differentiated

10

24.5

Stage at diagnosis

  

I,II

2

5

III (A, B, C)

33 (10, 12, 11)

80

IV

6

15

N of prior chemotherapy regimens

  

1

3

7

2

12

29

≥3

26

64

N of prior platinum-based regimens

  

1

23

56

2

9

22

3

9

22

  1. Abbreviations: ECOG PS, Eastern Cooperative Oncoloy Group Performance Status.